First Time Loading...
V

VIVA Biotech Holdings
HKEX:1873

Watchlist Manager
VIVA Biotech Holdings
HKEX:1873
Watchlist
Price: 0.61 HKD Market Closed
Updated: May 3, 2024

VIVA Biotech Holdings
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

VIVA Biotech Holdings
Revenue Peer Comparison

Comparables:
603259
300759
2269
300347
M
688114

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
V
VIVA Biotech Holdings
HKEX:1873
Revenue
¥2.2B
CAGR 3-Years
46%
CAGR 5-Years
59%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Revenue
¥40.3B
CAGR 3-Years
35%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Revenue
¥11.5B
CAGR 3-Years
31%
CAGR 5-Years
32%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Revenue
¥17B
CAGR 3-Years
45%
CAGR 5-Years
46%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Revenue
¥7.4B
CAGR 3-Years
32%
CAGR 5-Years
26%
CAGR 10-Years
36%
M
MGI Tech Co Ltd
SSE:688114
Revenue
¥4.2B
CAGR 3-Years
57%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is VIVA Biotech Holdings's Revenue?
Revenue
2.2B CNY

Based on the financial report for Dec 31, 2023, VIVA Biotech Holdings's Revenue amounts to 2.2B CNY.

What is VIVA Biotech Holdings's Revenue growth rate?
Revenue CAGR 5Y
59%

Over the last year, the Revenue growth was -9%. The average annual Revenue growth rates for VIVA Biotech Holdings have been 46% over the past three years , 59% over the past five years .